INTRODUCTION
============

Altered goblet cell physiology is a hallmark of inflammatory bowel disease (IBD) pathology ([@b28-0050457]). Individuals with Crohn's disease (CD) or ulcerative colitis (UC) have decreased numbers of goblet cells and reduced mucus thickness at presentation; however, goblet cells are replaced during active inflammation in individuals with CD but not in those with UC, suggesting an etiological role for goblet cell abnormalities in UC ([@b46-0050457]; [@b18-0050457]; [@b50-0050457]). The most commonly used chemically induced animal models of IBD utilize dextran sodium sulfate (DSS) or trinitrobenzene sulfonic acid (TNBS) to induce colitis ([@b48-0050457]). These chemically induced models share a conspicuous loss of goblet cells with a genetic model of spontaneous colitis, the *Winnie* mouse, demonstrating a conserved role for mucin production in maintaining intestinal barrier function ([@b23-0050457]; [@b12-0050457]).

Treatment with retinoids increases the risk of developing IBD in humans ([@b6-0050457]). The best-explored hypothesis to explain this effect is that retinoic acid (RA) in the intestine affects the production of regulatory dendritic and T cells, leading to immune dysregulation ([@b11-0050457]; [@b26-0050457]; [@b47-0050457]). Administration of exogenous RA is known to stimulate the release of mucin in cells of the upper airways and the addition of vitamin A to growing rats inhibits the differentiation of intestinal goblet cells ([@b17-0050457]). However, to our knowledge, the effects of exogenous RA on intestinal mucus secretion in response to inflammation have not been reported.

Intestinal development and physiology is highly conserved between mammals and zebrafish. Larval zebrafish intestinal physiology is amenable to relatively simple chemical-genetic interrogation by immersion of larvae in solutions of drugs and microinjection of morpholinos (modified oligonucleotides to knock down gene function) ([@b22-0050457]). Of importance to the modeling of IBD, the antimicrobial roles of NOD1 and NOD2 are conserved in zebrafish ([@b40-0050457]; [@b39-0050457]), as are many aspects of the host response to microbial colonization, including intestinal alkaline phosphatase expression and NFκB activation ([@b2-0050457]; [@b27-0050457]). Furthermore, zebrafish models of IBD-like enterocolitis have been recently described ([@b3-0050457]; [@b14-0050457]; [@b38-0050457]). Because zebrafish adaptive immunity is only functional after 4--6 weeks of development ([@b31-0050457]), larvae in the first week of development were used to investigate the effects of exogenous RA on intestinal physiology in the absence of adaptive immunity.

RESULTS
=======

DSS-induced enterocolitis is similar, but not identical, to TNBS-induced enterocolitis
--------------------------------------------------------------------------------------

A range of DSS doses were initially investigated to determine the maximum non-lethal dose that could be continuously tolerated by larvae at 3 days postfertilization (dpf). A dose of 0.5% (w/v) was established to be the highest concentration that did not cause significant mortality (data not shown). DSS-exposed larvae at 6 dpf manifested liver discoloration reminiscent of TNBS-exposed larvae but otherwise appeared morphologically normal ([Fig. 1A](#f1-0050457){ref-type="fig"}).

![**DSS exposure causes a distinct enterocolitis in zebrafish larvae when compared with TNBS exposure.** (A) Whole-mount live imaging of control, DSS-and TNBS-exposed larvae. Red arrows indicate liver. (B) Comparison of recovered microbiota from homogenates of control, DSS- and TNBS-exposed larvae (*n*=7). (C) Characterization of neutrophilic inflammation in zebrafish larvae by: (i) live imaging of *Tg(mpx:EGFP)^i114^* larvae; (ii) enumeration of neutrophils by FACS (*n*=5); and (iii) enumeration of intestinal neutrophils (*n*≥30 per group; three biological replicates). (D) Comparison of DAF-FM-DA staining in wild-type larvae treated as indicated. Red arrow indicates heart, blue arrow indicates cleithrum and yellow arrow indicates notochord. (E) Quantitative PCR analysis of pro-inflammatory cytokine and *proliferating cell nuclear antigen* gene expression in untreated and DSS-treated 6 dpf larvae (*n*=4). (F) Characterization of cellular proliferation in zebrafish larvae by: (i) live imaging of resazurin-stained larvae; (ii) quantification of fluorescence from live imaging (*n*=19); and (iii) manual counting of BrdU-positive cells in the gut and trunk (*n*=7). White arrowhead indicates otic vesicle and blue arrowhead indicates intestine in live images. Error bars indicate s.e.m.; \*\*\**P*\<0.0001, \*\**P*\<0.01 and \**P*\<0.05 as determined by ANOVA (B,C) or Student's *t*-tests (E,F). Scale bars: 1 mm.](DMM009365F1){#f1-0050457}

Enumeration of bacteria from whole larval homogenates revealed a significant (*P*\<0.0001, Student's *t*-test, *n*=7) increase in culturable bacterial load in DSS-, but not TNBS-, treated larvae compared with control larvae ([Fig. 1B](#f1-0050457){ref-type="fig"}).

A leukocyte response that can be monitored visually has been recognized as a useful readout of inflammation in neutrophilic inflammation models ([@b21-0050457]; [@b7-0050457]; [@b38-0050457]). The location and number of neutrophils in DSS-exposed larvae was characterized by live imaging of 6-dpf *Tg(mpx:EGFP)^i114^* larvae and by fluorescence activated cell sorting (FACS). Exposure to DSS resulted in a microbiota-dependent distribution of neutrophils away from the caudal hematopoietic tissue towards the intestine and epidermis, and an overall increase in neutrophil numbers, reminiscent of TNBS-induced enterocolitis ([Fig. 1C](#f1-0050457){ref-type="fig"}). Consistent with the previously described TNBS-induced enterocolitis model, the DSS-induced enterocolitis protocol was standardized to include addition of DSS at 3 dpf and assay of outcome at 6 dpf (3 days post-exposure).

Zebrafish larvae produce nitric oxide in response to inflammatory stress, and this can be live-imaged in larvae incubated with a 4-amino-5-methylamino-2′,7′-difluorofluorescein diacetate (DAF-FM-DA) probe ([@b19-0050457]; [@b32-0050457]). Larvae exposed to DSS manifested identical patterns and intensity of nitric oxide to control larvae, whereas TNBS exposure induced excess nitric oxide production in the region of the cleithrum and notochord ([Fig. 1D](#f1-0050457){ref-type="fig"}). To confirm the fidelity of the nitric oxide readout of TNBS-induced inflammation, nitric oxide production was assessed in TNBS-exposed larvae in which inflammation had been modified by the administration of antibiotics and anti-inflammatory drugs ([@b38-0050457]). The production of nitric oxide in these larvae was identical to control samples (supplementary material [Fig. S1](http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.009365/-/DC1)). Interestingly, the production of nitric oxide was increased in larvae treated with the non-steroidal anti-inflammatory drug 5-aminosalicylic acid. This observation suggests that administration of this drug alone induces a nitric oxide response in zebrafish larvae while not affecting other measures of inflammation ([@b38-0050457]).

To examine other measures of inflammation, quantitative PCR (qPCR) was undertaken. Exposure to DSS caused an appreciable upregulation of *ccl20*, *il1b*, *il23*, *il8*, *mmp9* and *tnfa* transcription ([Fig. 1E](#f1-0050457){ref-type="fig"}). Interestingly, the analysis of *proliferating cell nuclear antigen* (*pcna*) transcription revealed significantly reduced transcription of this marker of cellular proliferation (*P*\<0.01).

Further analysis of cellular proliferation was performed by adapting the resazurin reduction assay to enable fluorescent whole-mount live quantification, with confirmation by bromodeoxyuridine (BrdU) labeling of proliferative cells. Resazurin staining was most prominent in the otic vesicle and gut of 6-dpf larvae ([Fig. 1F](#f1-0050457){ref-type="fig"}). Comparison of fluorescence from control and DSS-exposed samples indicated reduced proliferation in DSS-exposed samples. This observation was confirmed by manual counting of BrdU-positive cells in the gut and trunk of control and DSS-exposed samples. There was no evidence of induction of cell death, as assessed by acridine orange or terminal deoxynucleotidyl transferase-mediated deoxyuridinetriphosphate nick end-labeling (TUNEL) staining (data not shown).

DSS induces the accumulation of acidic mucins in the intestinal bulb
--------------------------------------------------------------------

To examine changes to intestinal goblet cells in the DSS exposure model, alcian blue staining for acidic mucins was performed on whole-mount specimens. A striking feature of DSS-exposed samples was the appearance of alcian blue staining in the intestinal bulb ([Fig. 2A](#f2-0050457){ref-type="fig"}). We termed this accumulation of acidic mucins in the intestinal bulb the 'mucosecretory phenotype'. Sectioning revealed the stained substance to be in the lumen of the intestinal bulb, with no evidence of staining in intestinal bulb epithelial cells ([Fig. 2B](#f2-0050457){ref-type="fig"}). Further examination of transverse intestinal sections did not reveal overt histological changes at 6 dpf ([Fig. 2C,D](#f2-0050457){ref-type="fig"}).

Because there was no evidence to suggest transdifferentiation of intestinal bulb cells and a similar number of alcian-blue-stained goblet cells were observed in the mid intestine of untreated, DSS- and TNBS-exposed larvae at 6 dpf ([Fig. 2E](#f2-0050457){ref-type="fig"}), it was hypothesized that the stained substance was mucus produced by esophageal goblet cells. However, examination of alcian-blue-stained transverse esophageal sections did not reveal any changes in alcian blue staining within the esophageal goblet cells or in the thickness of mucus lining the esophageal--intestinal-bulb junction of DSS-exposed larvae when compared with controls (supplementary material [Fig. S2](http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.009365/-/DC1)).

To examine the effect of DSS or TNBS treatment on mucin gene expression, quantitative PCR analysis of *muc* (a putative zebrafish ortholog of the human esophagus-expressed MUC5 gene family) expression was carried out on control, DSS- and TNBS-exposed larvae. Exposure to TNBS, but not to DSS, increased the expression of *muc* ([Fig. 2F](#f2-0050457){ref-type="fig"}).

![**DSS exposure induces a mucosecretory phenotype in zebrafish larvae.** (A) Whole-mount control and DSS-exposed larvae stained with alcian blue. Blue arrows indicate intestinal bulb staining, red arrows indicate cartilage staining. Scale bar: 1 mm. (B) Longitudinal sections of intestinal bulb from control and DSS-exposed larvae, stained with alcian blue. Scale bar: 50 μm. (C) Longitudinal sections of the anterior-mid intestinal junction at the posterior edge of the swim bladder from control and DSS-exposed larvae, stained with alcian blue. Scale bar: 50 μm. (D) Longitudinal sections of the mid-distal intestinal junction from control and DSS-exposed larvae, stained with alcian blue. Scale bar: 50 μm. (E) Enumeration of mid intestinal goblet cells by manual counting (*n*≥28 per group; two biological replicates). (F) Quantitative PCR analysis of *muc* expression in control, DSS- and TNBS-exposed larvae (*n*=4). (G; left) Live image of 6-dpf *Tg(kita:GAL4, UAS:EGFP)* larvae; fin fold was defined as epidermis immediately ventral to the intestine. Scale bar: 1 mm. (G; right) Enumeration of GFP-expressing skin goblet cells on the fin fold of individual larvae (*n*≥12 per group; two biological replicates). Error bars represent s.e.m.; \**P*\<0.05, \*\*\**P*\<0.0001 as determined by ANOVA.](DMM009365F2){#f2-0050457}

To determine whether DSS-induced changes in goblet cell function were restricted to the esophagus, the fin fold mucus producing cells marked in *Tg(kita:GAL4, UAS:EGFP)* larvae were enumerated by live imaging ([@b13-0050457]; [@b43-0050457]). Exposure to DSS, but not to TNBS, was found to cause a small but statistically significant increase in the number of fin fold mucus-secreting cells ([Fig. 2G](#f2-0050457){ref-type="fig"}).

Because Kit expression has been observed in zebrafish mast cells ([@b10-0050457]), crosses with the *Tg(lyzC:dsRed)^nz50^* line were performed to determine whether the *Tg(kita:GAL4-EGFP)* construct drives expression in mast cells, because expression of *lyzC* has also been observed in zebrafish mast cells ([@b20-0050457]; [@b10-0050457]). Live imaging of untreated and TNBS-challenged compound transgenic larvae by confocal microscopy failed to detect any transgene coexpression, indicating that the *kita:GAL4-EGFP* double transgenic line does not label mast cells (supplementary material [Fig. S3](http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.009365/-/DC1)).

To investigate the possibility that DSS-induced mucus accumulation in the intestinal bulb is caused by reduced peristalsis, peristalsis in untreated, DSS- and TNBS-exposed larvae was observed. However, the rate of peristalsis did not differ between control (mean 3.577, *n*=26) and DSS-exposed (mean 3.448, *n*=29) larvae (95% CI of difference −0.6085 to 0.8658, determined by ANOVA), or between control and TNBS-exposed (mean 3.571, *n*=21) larvae (95% CI of difference −0.7953 to 0.8063, determined by ANOVA).

The mucosecretory phenotype is microbiota-dependent but independent of neutrophilic inflammation
------------------------------------------------------------------------------------------------

To investigate the role of inflammation in the mucosecretory phenotype, larvae were co-treated with DSS and the anti-inflammatory glucocorticoid dexamethasone to suppress inflammation. Dexamethasone co-treatment at a dose of 50 μg/ml prevented DSS-induced neutrophilic inflammation in *Tg(mpx:EGFP)^i114^* larvae ([Fig. 3A](#f3-0050457){ref-type="fig"}). However, dexamethasone treatment had no effect on the mucosecretory phenotype ([Fig. 3B](#f3-0050457){ref-type="fig"}). These data suggested that the DSS-induced mucosecretory phenotype was not dependent on inflammatory signaling.

The role of the microbiota as a trigger for the mucosecretory phenotype was investigated by co-administration of broad-spectrum antibiotics with DSS ([@b38-0050457]). Depletion of the microbiota prevented the appearance of the DSS-induced mucosecretory phenotype ([Fig. 3C](#f3-0050457){ref-type="fig"}).

DSS exposure is protective against further chemical-induced enterocolitis
-------------------------------------------------------------------------

Because increased mucin secretion protects against TNBS-induced colitis in mice ([@b30-0050457]), it was hypothesized that DSS-induced intestinal bulb mucin accumulation might protect larvae against TNBS challenge. To control for possible direct interaction between DSS and TNBS, exposure to 0.25% dextran was used as an additional control for this experiment ([Fig. 4A](#f4-0050457){ref-type="fig"}). Larvae that were coexposed to DSS and TNBS had less neutrophilic inflammation than larvae exposed to dextran and TNBS or TNBS alone ([Fig. 4B,C](#f4-0050457){ref-type="fig"}).

To complement this experiment, larvae were exposed to either dextran or DSS for 3 days and then challenged with a high dose of TNBS ([Fig. 4D](#f4-0050457){ref-type="fig"}). Analysis of larval survival and neutrophilic inflammation following high-dose TNBS treatment confirmed a protective effect of DSS pretreatment against TNBS-induced mortality and neutrophilic inflammation, respectively ([Fig. 4E,F](#f4-0050457){ref-type="fig"}).

![**The mucosecretory phenotype is microbiota-dependent but independent of neutrophilic inflammation.** (A) Live imaging of neutrophil distribution in *Tg(mpx:EGFP)^i114^* larvae co-treated with dexamethasone and DSS, and enumeration of intestinal neutrophils (*n*≥23 per group; two biological replicates). Scale bar: 1 mm. Error bars represent s.e.m.; \*\*\**P*\<0.0001 as determined by ANOVA. (B) Whole-mount larvae co-treated with dexamethasone and DSS, stained with alcian blue. Blue arrows indicate intestinal bulb staining; red arrows indicate cartilage staining. Scale bar: 1 mm. (C) Longitudinal sections of intestinal bulb from larvae co-treated with a cocktail of broad-spectrum antibiotics and DSS, stained with alcian blue. Scale bar: 50 μm.](DMM009365F3){#f3-0050457}

![**DSS-induced mucus secretion protects against further chemical-induced enterocolitis.** (A) Schematic describing the experimental procedure analyzed in panels B and C. (B) Live imaging of neutrophil distribution in *Tg(mpx:EGFP)^i114^* larvae co-treated as indicated. Scale bar: 1 mm. (C) Enumeration of intestinal neutrophils (*n*≥22 per group; two biological replicates). Error bars indicate s.e.m.; \*\*\**P*\<0.0001 as determined by ANOVA. (D) Schematic describing the experimental procedure reported in panels E and F. (E) Survival analysis of larvae treated as indicated from 3 dpf and exposed to 75 μg/ml TNBS from 6 dpf (*n*≥10 per group; six biological replicates). Error bars indicate 95% confidence interval. DSS vs control, DSS vs dextran: *P*\<0.0001 as determined by log-rank test. (F) Enumeration of intestinal neutrophils in larvae exposed to 75 μg/ml TNBS from 6 dpf and assayed at 24 hours post-TNBS exposure (*n*≥12 per group; three biological replicates). Error bars indicate s.e.m.; \*\*\**P*\<0.0001, \*\**P*\<0.01 as determined by ANOVA.](DMM009365F4){#f4-0050457}

Retinoic acid suppresses the mucosecretory phenotype
----------------------------------------------------

RA plays an important role in the epithelial transformation associated with Barrett's esophagus, whereby esophageal epithelial cells adopt intestinal phenotypes ([@b4-0050457]; [@b5-0050457]). Preliminary investigations by our group have indicated exogenous RA can induce in vivo transformation of zebrafish esophageal epithelial cells into intestinal bulb cells (M.V.F., unpublished data). RA is known to be a conserved modulator of intestinal epithelial cell differentiation in zebrafish through activation of Hoxc8 ([@b36-0050457]). Initial experiments suggested that coexposure to RA could suppress the DSS-induced mucosecretory phenotype (data not shown). Titration of micromolar concentrations of RA established a dose-dependent relationship between exogenous RA and suppression of the DSS-induced mucosecretory phenotype ([Fig. 5A](#f5-0050457){ref-type="fig"} and supplementary material [Fig. S4](http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.009365/-/DC1)). Co-administration of 1 μM RA to 3-dpf larvae was found to profoundly suppress the DSS-induced mucosecretory phenotype, while maintaining a normal morphology.

To examine the reversibility of the DSS-induced mucosecretory phenotype, larvae were exposed to DSS from 3 dpf and administered 1 μM RA at 3, 4 or 5 dpf. DSS-induced mucosecretion was assayed at 6 dpf, revealing an exposure-duration-dependent relationship between exogenous RA and suppression of the DSS-induced mucosecretory phenotype ([Fig. 5B](#f5-0050457){ref-type="fig"}).

To examine the effect of RA on esophageal *muc* expression, whole-mount in situ hybridization was carried out. Although the intestinal bulb staining for *muc* expression varied widely within untreated and RA-treated groups, esophageal expression of *muc* was profoundly reduced in larvae treated with RA ([Fig. 5C](#f5-0050457){ref-type="fig"}).

Histological examination of alcian-blue-stained esophageal sections of RA co-treated larvae revealed a decrease in the intensity of acidic mucin staining in the anterior esophagus in larvae that were co-treated with DSS and RA ([Fig. 5D](#f5-0050457){ref-type="fig"}). Examination of posterior esophagus sections also revealed a striking RA-induced loss of mucin staining in the pneumatic duct. However, the thickness of the mucus lining the esophageal--intestinal-bulb junction did not seem to be altered following administration of RA.

To further examine the effects of RA treatment on intestinal glycobiology, isolectin GS-IB4 was used to stain the esophagus--intestinal-bulb junction. The staining pattern of isolectin GS-IB4 was unchanged following exposure to RA, confirming the results from the examination of alcian-blue-stained esophageal--intestinal-bulb junction sections (supplementary material [Fig. S5A](http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.009365/-/DC1)). Furthermore, expression of RFP in the *Tg(ifabp:RFP)^as200^* transgenic line and neutral red uptake was unchanged, indicating normal intestinal bulb and mid intestinal specification (supplementary material [Fig. S5B and S5C](http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.009365/-/DC1), respectively) ([@b15-0050457]; [@b38-0050457]). Together, these data indicate that the dose and exposure parameters of RA used in this study selectively suppressed mucin production by esophageal cells but did not alter esophageal cell fate.

![**Retinoic acid suppresses the DSS-induced mucosecretory phenotype.** (A) Dose-response curve of the percentage of DSS-exposed larvae positive for the mucosecretory phenotype after the administration of a range of doses of RA (*n*≥20 per group; two biological replicates). (B) Proportion of DSS-exposed larvae positive or negative for the mucosecretory phenotype at 6 dpf after administration of RA at the day indicated. Fisher's exact test *P*-values vs untreated controls: 3 dpf\<0.0001, 4 dpf=0.0002, 5 dpf=0.0011; *n*≥20 per group, two biological replicates. (C) Whole-mount in situ hybridization detection of *muc* expression in the esophagus in control and RA-treated larvae. Blue arrows indicate the location of the esophagus. (D) Alcian-blue-stained esophageal sections of larvae treated with 1 μM RA and exposed to DSS. Arrows indicate the pneumatic duct. Scale bar: 50 μm.](DMM009365F5){#f5-0050457}

To determine whether RA administration affected neutrophilic inflammation in the DSS model, live imaging of *Tg(mpx:EGFP)^i114^* larvae was performed (supplementary material [Fig. S5D](http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.009365/-/DC1)). Administration of RA did not suppress DSS-induced neutrophilic inflammation.

Retinoic acid exposure exacerbates zebrafish enterocolitis
----------------------------------------------------------

Because TNBS-induced enterocolitis increased the expression of *muc*, it was hypothesized that suppression of *muc* expression by exogenous RA would exacerbate TNBS-induced enterocolitis. To test this hypothesis, larvae were coexposed to RA and TNBS from 3 dpf ([Fig. 6A](#f6-0050457){ref-type="fig"}). Analysis of larval survival revealed a marked decrease in the survival of larvae coexposed to RA and TNBS compared with larvae exposed to TNBS alone ([Fig. 6B](#f6-0050457){ref-type="fig"}). Furthermore, neutrophilic inflammation was increased in larvae that were coexposed with RA and TNBS compared with control or mono-exposed larvae ([Fig. 6C](#f6-0050457){ref-type="fig"}).

Because pre-exposure to DSS caused mucus secretion that seemed to protect against TNBS-induced mortality and neutrophilic inflammation, it was hypothesized that suppression of DSS-induced mucosecretion by exogenous RA would negate the protective effects of DSS pre-exposure. To test this hypothesis, larvae were coexposed to combinations of RA and DSS from 3 dpf and subsequently challenged with TNBS at 6 dpf ([Fig. 6D](#f6-0050457){ref-type="fig"}). Analysis of larval survival following TNBS challenge showed that, although coexposure to RA did not affect the survival of untreated or dextran-exposed larvae, the protective effect of DSS pre-exposure was suppressed by coexposure with RA ([Fig. 6E](#f6-0050457){ref-type="fig"}). Furthermore, coexposure to RA increased neutrophilic inflammation in larvae that were pre-exposed to DSS compared with larvae that were exposed to only DSS ([Fig. 6F](#f6-0050457){ref-type="fig"}).

DISCUSSION
==========

This paper presents a novel model of enterocolitis with increased mucin production. This model adds a useful tool for investigating inflammatory processes in zebrafish larvae. Furthermore, by using larval zebrafish, in which key cell types involved in enterocolitis can be studied in isolation from the adaptive immune system, exogenous RA has been shown to both suppress intestinal mucin production and exacerbate experimental inflammation.

The inflammatory parameters of the DSS-induced enterocolitis model seem to be largely similar to the TNBS-induced enterocolitis model (see [Table 1](#t1-0050457){ref-type="table"}). However, the difference in nitric oxide production between DSS- and TNBS-exposed larvae is striking because increased nitric oxide production has been previously observed as a core zebrafish inflammatory response ([@b32-0050457]). We speculate that the stark difference in the cellular proliferation response following exposure to TNBS (increased cellular proliferation) and DSS (decreased cellular proliferation) is a manifestation of the opposing stimulatory effects of TNBS haptenization and erosive effects of DSS on epithelial surfaces ([@b38-0050457]). Further study of the zebrafish DSS- and TNBS-induced enterocolitis models will lead to insights into innate-immunity-mediated intestinal inflammation.

Comparison of alterations to mucus physiology between animal models of intestinal inflammation reveals a striking difference between phenotypes, with a reduced number of goblet cells observed in adult mice and an increased number of goblet cells or accumulation of mucus observed in zebrafish larvae exposed to a high dose of TNBS or DSS, respectively (see [Table 1](#t1-0050457){ref-type="table"}). From the limited number of reports using zebrafish models of intestinal inflammation, the dichotomy in responses seems to be a function of the age of the organism. Whereas goblet cells seem to be susceptible to chemically induced cell death in adult animals, goblet cells in the larval zebrafish intestine seem to both be resistant to chemically induced cell death and increase their function in response to chemically induced intestinal damage. We speculate that the heightened resilience of goblet cells in the developing intestine is due to higher levels of growth factors associated with organogenesis and maturation.

![**Retinoic acid exposure exacerbates zebrafish enterocolitis.** (A) Schematic describing the experimental procedure reported in panel B. (B) Survival analysis of larvae co-treated with 1 μM RA and 75 μg/ml TNBS from 3 dpf (*n*≥20 per replicate; three biological replicates). Error bars indicate 95% confidence interval; *P*\<0.0001 as determined by log-rank test. (C) Enumeration of intestinal neutrophils in larvae co-treated with 1 μM RA and 25 μg/ml TNBS from 3 dpf (*n*≥22 per group; three biological replicates). Error bars indicate s.e.m.; \**P*\<0.05, \*\*\**P*\<0.0001 as determined by ANOVA. (D) Schematic describing the experimental procedure reported in panel E. (E) Survival analysis of larvae pre-treated as indicated from 3 dpf and exposed to 75 μg/ml TNBS at 6 dpf (*n*≥20 per group; four biological replicates). Error bars indicate 95% confidence interval; control vs RA: *P*=0.1815; dextran vs dextran + RA: *P*=0.2272; DSS vs DSS + RA: *P*\<0. 0001 as determined by log-rank test. (F) Enumeration of intestinal neutrophils in larvae pre-treated as indicated from 3 dpf and exposed to 75 μg/ml TNBS at 6 dpf and assayed at 24 hours post-TNBS exposure (*n*≥18 per group; three biological replicates). Error bars indicate s.e.m.; \*\**P\<*0.01 as determined by ANOVA.](DMM009365F6){#f6-0050457}

Comparison by electron microscopy of the ultrastructural morphology of the intestinal epithelium in chemically induced enterocolitis zebrafish models is necessary to complete our understanding of these models ([@b14-0050457]). Further comparison between adult and larval zebrafish models could further our understanding of the intestinal response to damage at different stages of development.

From the results of the microbiota depletion experiments, it has been hypothesized that DSS-induced mucin is produced in response to bacterial products penetrating the intestinal epithelium as a result of the erosive effects of DSS ([@b25-0050457]). Two zebrafish mutants with an accumulation of intestinal mucus, *stuffed* and *stuffy*, were characterized in a gynogenetic screen ([@b35-0050457]). It is possible that these mutants might phenocopy aspects of the DSS-induced mucosecretory phenotype, and further characterization of these mutants could yield insight into intestinal mucosecretory diseases such as cystic-fibrosis-associated small intestinal bacterial overgrowth ([@b8-0050457]).

The recent characterization of *Fusobacterium nucleatum*-stimulated MUC2 expression in humans ([@b9-0050457]) has demonstrated that specific components of the microbiota stimulate intestinal mucus production. Because the increase in total bacterial load following exposure to DSS could either be a cause or effect of the mucosecretory phenotype, it will be intriguing to study the compositional changes to the microbiota of inflamed larval zebrafish with molecular techniques. Additionally, because the larval zebrafish is amenable to gnotobiotic techniques ([@b41-0050457]), it provides a tractable model for the study of microbiota-induced mucin production.

Important limitations of chemically induced zebrafish larval models of intestinal inflammation for the modeling of IBD are the extraintestinal effects of immersion exposure on the epidermis and the lack of T cell involvement or a chronic disease stage with IBD-like histopathology (see [Table 1](#t1-0050457){ref-type="table"}). Conversely, the zebrafish larval platform offers the ability to perform high resolution live imaging, rapid genetic manipulation including the targeting of IBD susceptibility genes, and a level of experimental complexity and throughput necessary for performing high content disease modifier screens that are relevant to IBD. We postulate that the most important factors that influence an IBD model are that inflammation is microbiota-dependent and responsive to existing IBD therapies.

Quantification of intestinal neutrophilic inflammation by stereomicroscopy as defined in our methodology is an attractive readout for chemical and/or genetic disease modifier screening. It is important to acknowledge that this readout is complicated by the recruitment of neutrophils to the epidermis, including the epidermis of the larval intestinal tract, following exposure to either DSS or TNBS. However, as evidenced by our previous work and this paper, there is a strong correlation between the level of inflammation \[as determined by cytokine expression, neutrophil number, nitric oxide production (in the case of TNBS model) and bona fide intestinal epithelium-associated neutrophils (as determined by confocal microscopy)\] and the number of intestinal neutrophils as defined by our methodology ([@b38-0050457]).

Increased expression of *MUC5AC* is observed in IBD and other forms of colonic inflammation ([@b44-0050457]; [@b16-0050457]). Both the DSS and TNBS exposure models of zebrafish enterocolitis investigated in this report demonstrated increased mucus production, albeit by different mechanisms. Our finding that the increased mucus secretion caused by exposure to DSS protects larvae from TNBS-induced pathologies suggests a cytoprotective role for DSS-induced intestinal mucus accumulation.

Because intestinal mucus is known to be an important scaffold for antimicrobial activity in the mammalian intestine ([@b34-0050457]), it is likely that zebrafish intestinal mucus also has an antimicrobial function. The zebrafish larval intestinal damage models presented in this paper and elsewhere should be tractable platforms to explore intestinal mucus function ([@b39-0050457]; [@b38-0050457]).

###### 

Comparison of zebrafish models of intestinal inflammation with mouse chemically induced colitis models

![](DMM009365T1)

The association between retinoid treatment for dermatological conditions and the development of IBD is stronger for UC than it is for CD ([@b42-0050457]). Interestingly, UC, but not CD, is characterized by a deficient goblet cell phenotype ([@b18-0050457]). Our observations of RA-induced exacerbation of TNBS-induced enterocolitis, as analyzed by survival and neutrophilic inflammation, was surprising because RA has been largely demonstrated to have an anti-inflammatory effect by altering dendritic cell function ([@b11-0050457]; [@b26-0050457]; [@b47-0050457]). We hypothesize that this unexpected result is largely due to RA-induced suppression of intestinal mucus production rather than an effect on dendritic cells, because few dendritic cells are present in larval zebrafish ([@b33-0050457]; [@b49-0050457]).

Retinoid-containing drugs are primarily prescribed to adolescents for the treatment of acne; however, few studies have examined the effect of retinoid treatment on the developing intestine. A sole study on young rats has shown that hypervitaminosis A reduces the number of small intestine goblet cells and induces an inflammatory cell infiltrate ([@b17-0050457]). Our study adds to these findings by demonstrating that exogenous RA suppresses protective DSS-induced mucus secretion, subsequently leading to increased mortality and neutrophilic inflammation upon further enterocolitic challenge. Collectively, these data suggest that retinoids deliver a 'first hit' in a multistep etiology by suppressing intestinal *MUC* expression in adolescents. In a subset of already susceptible individuals, reduced mucus production and impaired mucus layer restoration could then combine with other genetic and environmental factors to trigger UC. Further study is warranted to examine the manifestation of these effects in patients undergoing treatment with retinoids.

METHODS
=======

Zebrafish manipulations
-----------------------

Zebrafish (*Danio rerio*) embryos were obtained from natural spawnings and raised until 1 dpf at 28.5°C in E3 embryo medium supplemented with methylene blue. E3 embryo medium used after 1 dpf did not contain methylene blue. Induction of enterocolitis by DSS exposure was carried out essentially as described for TNBS ([@b38-0050457]), with the substitution of DSS, or dextran as a control (MP Biomedicals), dissolved in E3 embryo medium for solutions of TNBS. Briefly, 10% (w/v) stock solutions of DSS or dextran were prepared in E3 at room temperature with gentle rocking. All analyses were performed at 6 dpf unless otherwise noted. Dexamethasone (Sigma-Aldrich) was dissolved in dimethyl sulfoxide (DMSO). All-trans RA (Sigma-Aldrich) was dissolved in DMSO and diluted to working concentrations with water.

Imaging
-------

Whole-mount imaging was carried out as previously described using a Nikon SMZ1500 stereomicroscope equipped with a DS-U2/L2 camera or a Nikon D-Eclipse C1 confocal microscope ([@b38-0050457]). Neutrophilic inflammation was analyzed as previously described ([@b38-0050457]). Briefly, *Tg(mpx:EGFP)^i114^* larvae were anesthetized in tricaine and mounted in 3% methylcellulose for imaging; 'intestinal neutrophils' were defined as EGFP-expressing cells within the two-dimensional boundary of the intestine from the intestinal bulb to the anus (see supplementary material [Fig. S6](http://dmm.biologists.org/lookup/suppl/doi:10.1242/dmm.009365/-/DC1) for illustration).

Bacterial enumeration
---------------------

Enumeration of bacteria from larval zebrafish was carried out as previously described with the modification that overnight growth was carried out at 28.5°C to recover commensal microbiota ([@b39-0050457]).

Fluorescence activated cell sorting
-----------------------------------

Cell sorting experiments were carried out as previously described ([@b38-0050457]). Briefly, larvae were dissociated in 0.25% trypsin-EDTA (Invitrogen) and analyzed using a BD LSRII.

Nitric oxide detection
----------------------

Live imaging detection of nitric oxide production was carried out as described ([@b32-0050457]). Briefly, larvae were incubated in a 10 μM solution of DAF-FM-DA (Molecular Probes) for 2 hours, rinsed in E3, anesthetized and imaged by epifluorescent microscopy.

Resazurin reduction assay
-------------------------

The resazurin reduction assay was adapted from the manufacturer's instructions. Briefly, larvae were incubated in a 1× solution of alamar blue (Invitrogen; final concentration 1 mg/ml resazurin) for 60 minutes, anesthetized and individually imaged by epifluorescent microscopy at fixed zoom and excitation intensity settings. Fluorescence intensity was quantified in ImageJ software Version 1.43 (National Institutes of Health).

Cell proliferation and death
----------------------------

Analysis of cell proliferation and death was performed as previously described using the In Situ Cell Proliferation Kit, FLUOS (Roche), the In Situ Cell Death Kit, TMR red (Roche) and acridine orange staining ([@b38-0050457]). Gut proliferation was enumerated by manual counting along the length of the gut, and trunk proliferation was enumerated by manual counting of a single field of view immediately posterior to the swim bladder.

Quantitative PCR
----------------

The Ambion MicroPoly(A)Purist kit was used to purify RNA from pools of whole larvae for reverse transcription ([@b29-0050457]). Reverse transcription and quantitative PCR was carried out as previously described ([@b40-0050457]). Additional primers for amplifying *il23* were previously described ([@b24-0050457]). Primers to amplify *muc* (5′-TGTGGACCCGAGCAAAAATTA-3′ and 5′-AGCTAACTCGAATCCCACATCAC-3′) were designed in Primer Express (Applied Biosystems).

Histological analysis
---------------------

Larvae were fixed in paraformaldehyde, rinsed in acidic ethanol and stained with alcian blue. Unbound stain was removed by repeated rinsing with acidic ethanol prior to whole-mount imaging or preparation for histological sectioning. Specimens for sectioning were embedded in agarose, infiltrated with paraffin, cut into 7 μm sections, rehydrated and counterstained with nuclear fast red (Vector Labs). Histological imaging was carried out on a Leica DMR compound microscope with a DFC420C camera.

Whole-mount in situ hybridization
---------------------------------

PCR with gene-specific primers (5′-CCTACACCTCCTCC-AGTTATCTGC-3′ and 5′-CACTCGCCTTTTTGTTCCACG-3′) for *muc* (CR854881.2-201; NCBI accession number: 100148804) were used to amplify a 908 bp product from larval cDNA. This PCR product was cloned and transcribed to create riboprobes. Whole-mount in situ hybridization was carried out as described ([@b45-0050457]), and no staining was observed in sense strand control riboprobes.

Lectin staining
---------------

Lectin staining was carried out as described ([@b1-0050457]). Briefly, larvae were fixed for 2 hours at room temperature or overnight at 4°C, rinsed with PBST, blocked in PBST supplemented with 2% (w/v) blocking solution (Roche), incubated in PBST supplemented with 2% blocking solution and 10 μg/ml lectin, rinsed with PBST and imaged by epifluorescent microscopy.

Statistical analyses
--------------------

All statistical tests were carried out with GraphPad Prism version 5.0a for Mac (GraphPad Software). Multiple comparisons within ANOVA tests were carried out by Tukey test.

###### TRANSLATIONAL IMPACT

**Clinical issue**

Retinoids, such as isotretinoin, are indicated for use in treating severe acne but are recognized to cause a number of serious side effects. Epidemiological studies have linked isotretinoin exposure to the etiology of inflammatory bowel disease (IBD). Mechanisms by which retinoids have been proposed to cause IBD include dysregulation of the adaptive immune system and alteration of intestinal mucus physiology. Retinoids are known to dry out epithelial barriers, including the skin and airways, but there is little biological evidence that exposure to retinoids modulates IBD-relevant intestinal mucus physiology.

**Results**

This research examined a novel zebrafish model of IBD induced by immersing zebrafish larvae in dextran sodium sulfate (DSS), a chemical that is commonly used to induce colitis in rodent models of IBD. Analysis of this model revealed a protective mucosecretory response to enterocolitis that was similar to that seen in individuals with IBD. Administration of exogenous retinoic acid was found to suppress both homeostatic and DSS-induced mucus production by the intestinal epithelium. Suppression of either homeostatic or DSS-induced mucus production was correlated with increased neutrophilic inflammation and larval mortality following further enterocolitic challenge.

**Implications and future directions**

This study provides direct evidence that exposure to retinoids disrupts intestinal mucus physiology in a whole animal. The data suggest that drugs such as isotretinoin might contribute to IBD pathogenesis by compromising both the physiological production of intestinal barrier mucus and the stress-induced production of protective mucus.

Supplementary Material
======================

###### Supplementary Material
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